Clinical trial
Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in…
NCT00331786 · Stony Brook University, Other · Completed
Key facts
| NCT number | NCT00331786 |
|---|---|
| Title | Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer |
| Official title | Phase I Multiple-Dose Safety, Pharmacokinetic and Pharmacodynamic Clinical Study of Nitric Oxide Releasing Aspirin (NCX 4016) |
| Lead sponsor | Stony Brook University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | nitric oxide-releasing acetylsalicylic acid derivative, laboratory biomarker analysis, biopsy |
| Enrollment | 240 |
| Start date | Jul 1, 2006 |
| First posted | May 31, 2006 |
| Last update posted | Feb 9, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: